GleamWall
中文EN

BIO BIO-RAD LABORATORIES, INC.

Laboratory Analytical Instruments · NYSE · SEC CIK 12208 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.4%
TTM net income YoY251.3%
TTM EPS YoY254.8%
Revenue 3-yr CAGR-1.6%
Net income 3-yr CAGR—

Margins

Gross margin51.3%
Operating margin-2.4%
Net margin39.5%
FCF margin12.7%
EBITDA margin—

Returns

ROE14.3%
ROA10.0%
ROIC (approx.)-0.6%
Asset turnover0.25x

Leverage & solvency

Liabilities / assets29.5%
Debt / equity0.11x
Current ratio3.18x
Interest coverage-1.27x

Cash quality & payout

Operating cash flow / net income0.46x
Accruals ratio5.4%
Payout ratio—
Capex / revenue5.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q42024-12-31
Income statement
Revenue$656.40M$651.00M$592.10M$693.20M$653.00M$651.60M$585.40M$667.50M
Cost of revenue$327.80M$305.20M$282.70M$348.00M$309.60M$306.30M$279.40M$325.56M
Gross profit$328.60M$345.80M$309.40M$345.20M$343.40M$345.30M$306.00M$342.00M
R&D expense$71.40M$61.20M$62.90M$70.30M$71.30M$60.50M$73.50M$79.62M
SG&A expense$257.10M$212.00M$212.40M$221.00M$206.80M$207.70M$208.80M$203.96M
Operating income-$49.70M$72.60M$34.10M-$118.90M$65.30M$77.10M$23.70M$58.33M
Interest expense$12.30M$12.10M$12.30M$12.10M$12.30M$12.60M$12.00M$12.19M
Pretax income$538.70M$542.10M-$689.80M$929.20M-$431.10M$414.00M$83.40M-$908.90M
Income tax$80.10M$170.70M-$162.70M$209.20M-$89.20M$96.20M$19.40M-$193.12M
Net income$458.60M$371.40M-$527.10M$720.00M-$341.90M$317.80M$64.00M-$715.80M
EPS (basic)17.1313.89-19.55—-12.7011.672.29-25.57
EPS (diluted)17.0213.85-19.55—-12.7011.672.29-25.57
Weighted avg. shares (diluted)26.95M26.81M26.96M—26.92M27.23M27.95M—
Banking
Provision for credit losses———$0————
Balance sheet
Cash & equivalents$465.30M$517.00M$507.20M$529.80M$395.80M$369.30M$521.40M$489.80M
Short-term investments$1.20B$1.10B$1.06B$1.01B$1.02B$1.00B$1.14B$1.18B
Receivables$422.60M$441.80M$426.20M$460.60M$464.70M$469.90M$424.70M$452.50M
Inventory$783.90M$780.60M$770.50M$740.70M$783.20M$798.80M$790.10M$760.00M
Current assets$3.08B$3.02B$2.94B$2.91B$2.84B$2.81B$3.04B$3.03B
PP&E, net$505.70M$517.90M$527.50M$539.90M$540.20M$549.70M$528.50M$528.10M
Goodwill$573.00M$574.30M$577.10M$579.80M$578.70M$581.60M$414.60M$410.50M
Intangibles$104.40M$160.00M$166.80M$174.30M$388.40M$396.90M$296.10M$293.60M
Total assets$10.78B$10.25B$9.79B$10.58B$9.70B$10.21B$9.53B$9.36B
Current liabilities$969.10M$961.30M$917.00M$517.00M$522.30M$548.90M$506.60M$467.80M
Long-term debt$803.10M$803.00M$802.90M$1.20B$1.20B$1.20B$1.20B$1.20B
Total debt$803.10M$803.00M$802.90M$1.20B$1.20B$1.20B$1.20B$1.20B
Total liabilities$3.18B$3.08B$2.94B$3.12B$2.96B$3.09B$2.85B$2.79B
Shareholders' equity$7.60B$7.17B$6.85B$7.45B$6.74B$7.13B$6.68B$6.57B
Net debt$337.80M$286.00M$295.70M$671.90M$805.60M$831.80M$679.30M$710.60M
Cash flow statement
Operating cash flow$96.40M$98.70M$108.10M$164.90M$120.90M$116.50M$129.90M$124.15M
Capital expenditure$31.20M$32.00M$30.00M$45.80M$31.70M$45.70M$34.40M$42.91M
Free cash flow$65.20M$66.70M$78.10M$119.10M$89.20M$70.80M$95.50M$81.24M
Investing cash flow-$145.90M-$66.70M-$93.20M-$34.20M-$43.00M-$115.40M$2.90M-$30.54M
Financing cash flow-$1.60M-$27.60M-$44.00M$3.30M-$52.50M-$136.30M-$97.70M-$26.25M
Stock-based compensation$15.50M$14.50M$15.00M$15.90M$14.90M$11.90M$15.30M$16.40M
Share buybacks$0$31.50M$47.80M$0$53.40M$140.20M$101.90M$14,000

Free plan shows the latest 8 periods; Pro shows all 70 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.